These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Virus specific tolerance enhanced efficacy of cancer immuno-virotherapy. Sobhanimonfared F; Bamdad T; Sadigh ZA; Choobin H Microb Pathog; 2020 Mar; 140():103957. PubMed ID: 31891795 [TBL] [Abstract][Full Text] [Related]
7. Fusogenic vesicular stomatitis virus combined with natural killer T cell immunotherapy controls metastatic breast cancer. Nelson A; McMullen N; Gebremeskel S; De Antueno R; Mackenzie D; Duncan R; Johnston B Breast Cancer Res; 2024 May; 26(1):78. PubMed ID: 38750591 [TBL] [Abstract][Full Text] [Related]
8. Vesicular Stomatitis Virus (VSV) G Glycoprotein Can Be Modified to Create a Her2/Neu-Targeted VSV That Eliminates Large Implanted Mammary Tumors. Gao Y; Bergman I J Virol; 2023 Jun; 97(6):e0037223. PubMed ID: 37199666 [TBL] [Abstract][Full Text] [Related]
9. Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis. Ben Yebdri F; Van Grevenynghe J; Tang VA; Goulet ML; Wu JH; Stojdl DF; Hiscott J; Lin R Mol Ther; 2013 Nov; 21(11):2043-53. PubMed ID: 23985699 [TBL] [Abstract][Full Text] [Related]
10. Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy. Bishnoi S; Tiwari R; Gupta S; Byrareddy SN; Nayak D Viruses; 2018 Feb; 10(2):. PubMed ID: 29473868 [TBL] [Abstract][Full Text] [Related]
11. Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia. Betancourt D; Ramos JC; Barber GN J Virol; 2015 Dec; 89(23):11786-800. PubMed ID: 26378177 [TBL] [Abstract][Full Text] [Related]
12. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis. Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245 [TBL] [Abstract][Full Text] [Related]
13. Lassa-vesicular stomatitis chimeric virus safely destroys brain tumors. Wollmann G; Drokhlyansky E; Davis JN; Cepko C; van den Pol AN J Virol; 2015 Jul; 89(13):6711-24. PubMed ID: 25878115 [TBL] [Abstract][Full Text] [Related]
14. Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer. Yu N; Puckett S; Antinozzi PA; Cramer SD; Lyles DS J Virol; 2015 May; 89(10):5250-63. PubMed ID: 25741004 [TBL] [Abstract][Full Text] [Related]
15. Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. Hastie E; Cataldi M; Moerdyk-Schauwecker MJ; Felt SA; Steuerwald N; Grdzelishvili VZ Oncotarget; 2016 Sep; 7(38):61601-61618. PubMed ID: 27533247 [TBL] [Abstract][Full Text] [Related]
16. Vesicular stomatitis virus: re-inventing the bullet. Lichty BD; Power AT; Stojdl DF; Bell JC Trends Mol Med; 2004 May; 10(5):210-6. PubMed ID: 15121047 [TBL] [Abstract][Full Text] [Related]